710
Views
19
CrossRef citations to date
0
Altmetric
Perspective

Targeted protein-omic methods are bridging the gap between proteomic and hypothesis-driven protein analysis approaches

, , &
Pages 565-575 | Published online: 09 Jan 2014

Figures & data

Figure 1. Experimental setup for hypothesis-driven, ‘protein-omic’ and proteomic approaches.

(A) Each arrow indicates an experimental condition, which may represent the stimulation or inhibition of components of a biological system. Circles represent a protein modification measured. (B) Resulting data matrix from the experimental set up. Each column represents an experimental condition and the length of the column indicates the depth of measured protein data space.

Figure 1. Experimental setup for hypothesis-driven, ‘protein-omic’ and proteomic approaches.(A) Each arrow indicates an experimental condition, which may represent the stimulation or inhibition of components of a biological system. Circles represent a protein modification measured. (B) Resulting data matrix from the experimental set up. Each column represents an experimental condition and the length of the column indicates the depth of measured protein data space.
Figure 2. Targeted protein-omic platforms.

Four methodologies are indicated: (A) forward-phase arrays, where samples are labeled and applied to immobilized antibodies specific to certain proteins on nitrocellulose slides; (B) sandwich arrays, where captured proteins are detected by a second labeled antibody targeted to that protein; (C) reverse-phase lysate arrays, where complex mixtures of proteins are printed and immobilized onto slides and then specific proteins detected with a primary antibody; and (D) micro-western arrays, where samples are printed, electrophoresed to separate proteins based on size, then transferred to nitrocellulose, and then specific proteins detected with primary antibodies. A near-infrared dye-labeled secondary antibody can be used to generate fluorescent signal in (C & D) when used with the LI-COR Odyssey near-infrared scanner. Green shapes denote the targeted protein of interest while blue shapes denote proteins that nonspecifically cross-react with antibodies. The filled circles underneath each array represent the strength of each platform with respect to each criterion on the left.

Figure 2. Targeted protein-omic platforms.Four methodologies are indicated: (A) forward-phase arrays, where samples are labeled and applied to immobilized antibodies specific to certain proteins on nitrocellulose slides; (B) sandwich arrays, where captured proteins are detected by a second labeled antibody targeted to that protein; (C) reverse-phase lysate arrays, where complex mixtures of proteins are printed and immobilized onto slides and then specific proteins detected with a primary antibody; and (D) micro-western arrays, where samples are printed, electrophoresed to separate proteins based on size, then transferred to nitrocellulose, and then specific proteins detected with primary antibodies. A near-infrared dye-labeled secondary antibody can be used to generate fluorescent signal in (C & D) when used with the LI-COR Odyssey near-infrared scanner. Green shapes denote the targeted protein of interest while blue shapes denote proteins that nonspecifically cross-react with antibodies. The filled circles underneath each array represent the strength of each platform with respect to each criterion on the left.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.